Literature DB >> 17483078

Effectiveness and limitation of gamma knife radiosurgery for relapsed central nervous system lymphoma: a retrospective analysis in one institution.

Yosuke Matsumoto1, Shigeo Horiike, Yoshiko Fujimoto, Daisuke Shimizu, Yuriko Kudo-Nakata, Satoshi Kimura, Manabu Sato, Kenichi Nomura, Hiroto Kaneko, Yutaka Kobayashi, Chihiro Shimazaki, Masafumi Taniwaki.   

Abstract

We describe 6 patients with relapsed central nervous system lymphoma (CNSL) treated with Gamma Knife radiosurgery (GKR). The histologic diagnosis in all 6 patients was diffuse large B-cell lymphoma without human immunodeficiency virus infection. Two patients had intracranial relapse of primary CNSL, and the remaining 4 had CNS relapse of systemic lymphoma. All patients were treated with GKR without severe adverse effects, and all but 1 patient received subsequent chemotherapy shortly after GKR. Four patients showed a complete response, and the remaining 2 patients had a partial response or stable disease. Although the neurologic symptoms disappeared or improved markedly in all patients, all of the diseases recurred or progressed 3 to 13 months after the first GKR. A second GKR was eventually performed in 4 patients. The median overall survival and progression-free survival times after the first GKR were 17 and 11 months, respectively. In our experience, GKR seems to be a useful procedure for the treatment of relapsed CNSL, because it facilitates excellent local control in a short-term treatment period without severe complications, although the efficacy period is not long enough.

Entities:  

Mesh:

Year:  2007        PMID: 17483078     DOI: 10.1532/IJH97.06205

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  25 in total

Review 1.  Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.

Authors:  B D Cheson; S J Horning; B Coiffier; M A Shipp; R I Fisher; J M Connors; T A Lister; J Vose; A Grillo-López; A Hagenbeek; F Cabanillas; D Klippensten; W Hiddemann; R Castellino; N L Harris; J O Armitage; W Carter; R Hoppe; G P Canellos
Journal:  J Clin Oncol       Date:  1999-04       Impact factor: 44.544

2.  Dementia following treatment of brain tumors with radiotherapy administered alone or in combination with nitrosourea-based chemotherapy: a clinical and pathological study.

Authors:  M C Vigliani; C Duyckaerts; J J Hauw; M Poisson; H Magdelenat; J Y Delattre
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

3.  Central nervous system involvement in patients with diffuse aggressive non-Hodgkin's lymphoma.

Authors:  R M Bashir; P J Bierman; J M Vose; D D Weisenburger; J O Armitage
Journal:  Am J Clin Oncol       Date:  1991-12       Impact factor: 2.339

4.  Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting.

Authors:  T A Lister; D Crowther; S B Sutcliffe; E Glatstein; G P Canellos; R C Young; S A Rosenberg; C A Coltman; M Tubiana
Journal:  J Clin Oncol       Date:  1989-11       Impact factor: 44.544

Review 5.  Primary central nervous system lymphoma of the brain stem responding favorably to radiosurgery: a case report and literature review.

Authors:  Peter G Campbell; Ajay Jawahar; Marjorie R Fowler; Allyson Delaune; Anil Nanda
Journal:  Surg Neurol       Date:  2005-11

6.  Retrospective study of prognostic factors in non-Hodgkin lymphoma secondarily involving the central nervous system.

Authors:  Kristoph Jahnke; Eckhard Thiel; Peter Martus; Stefan Schwartz; Agnieszka Korfel
Journal:  Ann Hematol       Date:  2005-08-13       Impact factor: 3.673

7.  Gamma Knife radiosurgery in AIDS-related primary central nervous system lymphoma.

Authors:  A Nicolato; M A Gerosa; R Foroni; E Piovan; P G Zampieri; A Pasoli; M G Giri; P Iuzzolino; C Ghimenton; R Luzzati
Journal:  Stereotact Funct Neurosurg       Date:  1995       Impact factor: 1.875

8.  Central nervous system relapse in non-Hodgkin lymphoma. A single-center study of 532 patients.

Authors:  E L Bollen; R E Brouwer; S Hamers; J Hermans; M Kluin; S U Sankatsing; R V A-Tjak; M V Charvat; J C Kluin-Nelemans
Journal:  Arch Neurol       Date:  1997-07

Review 9.  Treatment-induced leukoencephalopathy in primary CNS lymphoma: a clinical and autopsy study.

Authors:  Rose Lai; Lauren E Abrey; Marc K Rosenblum; Lisa M DeAngelis
Journal:  Neurology       Date:  2004-02-10       Impact factor: 9.910

10.  Long-term remission of primary central nervous system lymphoma by intensified methotrexate chemotherapy.

Authors:  Takao Watanabe; Yoichi Katayama; Atsuo Yoshino; Chiaki Komine; Takakazu Yokoyama; Takao Fukushima
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

View more
  12 in total

1.  Combined diffusion and perfusion MR imaging as biomarkers of prognosis in immunocompetent patients with primary central nervous system lymphoma.

Authors:  F E Valles; C L Perez-Valles; S Regalado; R F Barajas; J L Rubenstein; S Cha
Journal:  AJNR Am J Neuroradiol       Date:  2012-08-30       Impact factor: 3.825

2.  Pilot study of gamma-knife surgery-incorporated systemic chemotherapy omitting whole brain radiotherapy for the treatment of elderly primary central nervous system lymphoma patients with poor prognostic scores.

Authors:  Joon Cho; Jihye Kim; Hui Jin Ryu; Hong Gee Roh; Hyun Woo Chung; Young-Cho Koh; Mark Hong Lee; Yoon-Ho Ko; Sung-Yong Kim
Journal:  Med Oncol       Date:  2014-02-05       Impact factor: 3.064

3.  Treatment and prophylaxis of hematologic malignancy in the central nervous system.

Authors:  Seema Nagpal; Lawrence Recht
Journal:  Curr Treat Options Neurol       Date:  2011-08       Impact factor: 3.598

4.  Outcomes after stereotactic radiosurgery for CNS lymphoma.

Authors:  Joshua D Palmer; Deepak Bhamidipati; Gaurav Shukla; Narendranath Epperla; Jon Glass; Lyndon Kim; Wenyin Shi
Journal:  J Neurooncol       Date:  2020-02-27       Impact factor: 4.130

5.  Relapsed or refractory primary central nervous system lymphoma radiosurgery: Report of the International Gamma Knife Research Foundation.

Authors:  Samuel M Shin; Joshua S Silverman; Greg Bowden; David Mathieu; Huai-Che Yang; Cheng-Chia Lee; Moses Tam; Paul Szelemej; Anthony M Kaufmann; Or Cohen-Inbar; Jason Sheehan; Ajay Niranjan; L Dade Lunsford; Douglas Kondziolka
Journal:  J Radiosurg SBRT       Date:  2017

6.  Stereotactic radiosurgery in combination with up-front high-dose methotrexate as a first-line treatment for newly diagnosed primary central nervous system lymphoma.

Authors:  Seiichiro Hirono; Yasuo Iwadate; Yoshinori Higuchi; Toru Serizawa; Osamu Nagano; Tomoro Matsutani; Naokatsu Saeki
Journal:  J Neurooncol       Date:  2015-04-25       Impact factor: 4.130

7.  Treatment of leptomeningeal spread of NSCLC: a continuing challenge.

Authors:  Seema Nagpal; Jonathan Riess; Heather Wakelee
Journal:  Curr Treat Options Oncol       Date:  2012-12

8.  Low-dose whole brain radiotherapy combined with radiosurgery for primary CNS lymphoma achieving partial response to induction methotrexate-based chemotherapy.

Authors:  Daniel S Oh; James A Vredenburgh; David A Reardon; Leonard R Prosnitz; Jon P Gockerman; John H Sampson; Christopher R Kelsey; John P Kirkpatrick
Journal:  J Radiosurg SBRT       Date:  2014

Review 9.  Is There an Indication for First Line Radiotherapy in Primary CNS Lymphoma?

Authors:  Clemens Seidel; Christine Viehweger; Rolf-Dieter Kortmann
Journal:  Cancers (Basel)       Date:  2021-05-25       Impact factor: 6.639

10.  Diffusion-weighted MR imaging derived apparent diffusion coefficient is predictive of clinical outcome in primary central nervous system lymphoma.

Authors:  R F Barajas; J L Rubenstein; J S Chang; J Hwang; S Cha
Journal:  AJNR Am J Neuroradiol       Date:  2009-09-03       Impact factor: 4.966

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.